Eve McDavid

Arena BioWorks shuts down after investors pull plug on big bold bet to reinvent biotech, founder Stuart Schreiber confirmed to me. He pointed to biotech macro conditions and also investors seeking bigger returns on AI and tech as the problem. But he said that the investors are letting Arena's scientists keep their preclinical drug programs and find a new home for them. More details in my story for Endpoints News: https://lnkd.in/epNPw8eG #ArenaBioworks #Biotech #Biomedicine #BiomedicalResearch #ScienceFunding #LifeSciences #DrugDiscovery

55

7 Comments

Startup Physicians just published the first-ever Rising Stars in Healthcare Innovation list. 15 physician co-founders of eary-stage ventures, nominated by healthcare investors, accelerator leaders, and fellow clinicians, then reviewed by a Selection Council. A few highlights from the 2026 list: - Psycho-oncologist Kyle Lavin co-founded Cerula Care to embed behavioral health into cancer care workflows, raising $5M. - Reproductive psychiatrist Sipra Laddha, MD built LunaJoy Health across 11 states, raising $4.2M backed by Y Combinator and Goodwater Capital to close maternal mental health gaps. - Cardiac electrophysiologist Rachita Navara, MD, FACC, FHRS co-founded SafeBeat Rx — the first FDA-cleared ECG AI platform to recommend antiarrhythmic treatment — backed by Y Combinator and three NIH grants. - Dermatologist Osama Hashmi MD co-founded Impiricus, named Deloitte's #1 fastest-growing company in North America in 2025, after raising $4.6M led by FCA Venture Partners. - Primary care physician Muthu Alagappan, MD co-founded Counsel Health and recently raised a $25M Series A led by a16z and GV for his AI-native care platform, now serving 100,000+ members nationwide. Link to the full list in comments. Congratulations to all 15 honorees. Physicians who build change what healthcare becomes - at scale. Ann Wu | Anurag Gupta, MD, MBA, MMSc | David Johnson | Jasen Gundersen MD, MBA | Kalie Dove-Maguire, MD | Kristin Andruska, MD, PhD | Michael Fang, MD | Michael Vincent Smith, MD, FACC, FACS, FCCP | Saamer Siddiqi M.D. | Victor Sadauskas

60

6 Comments

Advanced cancer care shouldn’t remain out of reach simply because of affordability. CAR T-cell therapy represents a breakthrough for patients with relapsed or refractory blood cancers—but in India, access has been limited by high upfront costs and fragmented financing options. That’s why I’m glad to share that ImpactGuru and CarePal Money have partnered with Immuneel Therapeutics Pvt. Ltd. to build an integrated financial access model for CAR T-cell therapy in India. This collaboration brings together three critical pillars: Clinical innovation through globally benchmarked CAR T-cell therapies by Immuneel Therapeutics Community-powered crowdfunding via Impact Guru, backed by a donor network of over 50 lakh contributors Structured healthcare lending through CarePal Money, connecting patients to tailored medical loans via NBFC partners Together, this dual pathway allows patients and families to mobilise community support while also accessing organised credit—offering flexibility, continuity of care, and financial security at a deeply vulnerable moment. As Amit Mookim rightly said, scientific breakthroughs only create real impact when they reach those who need them most. We strongly believe that medical innovation must be matched with financial innovation. Our goal is not just to support individual patients, but to help create a scalable access framework for advanced therapies in emerging markets—one that complements public health systems, insurance, and future reimbursement pathways. This is a meaningful step toward making cutting-edge cancer care more inclusive, humane, and accessible. https://lnkd.in/dVmdNecu Khushboo Jain, Vikas Kaul, Sahil Lakshmanan

46

1 Comment

SimplePractice has released our Annual State of Private Practice Report. This dives deep into my new world of mental healthcare and provides insights gathered from the backbone and driving force behind it, clinicians. Shoutout to Lindsay Oberleitner, Ph.D., LP for the amazing work on this!

5

1 Comment

Ask a tech founder what will transform healthcare in the next decade: "AI." Ask a physician: "GLP-1s." One of these groups actually treats patients. Kameron Matthews, MD, JD, FAAFP and Shelli Pavone of Inlightened both chose GLP-1s without hesitation on Christina Farr' podcast Lifers. The evidence is already here: life-changing weight loss, diabetes reversal, improved cardio function, metabolic disease treatment. And we're just scratching the surface as prices drop and access expands. Meanwhile, AI's impact on actual patient outcomes? "Very slow," according to Matthews.

30

8 Comments

📢 New Research Published: "Flipping the Script: Low Income #Cancer Patients Lead in #Telehealth Use." A surprising new study challenges assumptions about the digital divide in healthcare. https://lnkd.in/ekkhFTRB While many believe low income patients face the biggest barriers to telehealth, new evidence says otherwise — some low income #cancerpatients are actually using telehealth at higher rates than higher income groups. Published in Telehealth and #Medicine Today (THMT), this study by Elaine Chambers, Southern University and A&M College- Baton Rouge, uses more than a decade of national data (NHIS 2011–2023) to explore who’s really leading in virtual care adoption — and why. 📌 Key finding: Low income cancer patients were significantly more likely to use telehealth services compared to their higher-income counterparts — even after adjusting for socioeconomic and structural factors. 👉 The takeaway? When the right enabling conditions are present — such as education, employment, and accessible technology — low-income patients embrace telehealth, reshaping our understanding of health equity in oncology care. #Telehealth #DigitalHealth #Oncology #HealthEquity #CancerCare #PublicHealth #HealthcareInnovation #THMT #OpenAccess American Cancer Society American Telemedicine Association ISfTE (International Society for Teacher Education)

8

On this episode of #TheShot of #DigitalHealth Therapy, Jim Joyce and I welcomed Jason Campana, the freshly minted CEO of LifeSpeak Inc. who once learned business the hard way - running a painting company without knowing how to paint. From questionable brush strokes to scaling global wellness platforms, Jason’s career is proof that grit beats polish. Tune-in now: 📺 - YouTube - https://lnkd.in/dt87767R 🍏 - Spotify - https://lnkd.in/duTB5XXv 🍎 - Apple - https://lnkd.in/dunVHbW2 🔑 Highlights: 📉 Lessons learned from being a public company (and back to private) 🔗 Merging multiple brands into one unified platform 🧩 Employers’ growing point solution fatigue 📈 Scaling wellbeing with personalization, prevention, AI and human-in-the-loop Fun mentions as always: John Brownlee Kyle Rolfing Jason Von Bank Michael Held

31

3 Comments

At the 2025 Forbes Healthcare Summit, Alec C. Kimmelman, MD, PhD, Dean of NYU Grossman School of Medicine and CEO of NYU Langone Health, shared exclusive insights into their rigorous AI product testing process. His emphasis is on ensuring integration is safe, trusted, and always maintains the human touch. Presented by NYU Langone Health Learn More: https://bit.ly/44Fhx7V

17

Investors are waking up to a $360B “ghost market” in women’s health, as highlighted by Amboy Street Ventures. Did you know autoimmune disease is a major part of that gap? Here’s how cross-sector collaboration could unlock higher #ROI across the women’s health ecosystem — by addressing autoimmune disease as a core driver of value. 🌸 $𝟭𝟯𝟭𝗕 𝗠𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗲: Hormonal shifts during menopause disrupt immune balance, often triggering or worsening autoimmune conditions — opening new demand for immunology-informed therapeutics, diagnostics, and lifestyle solutions. ⚕️$𝟮���𝗕 𝗛𝗲𝗮𝗿𝘁 𝗛𝗲𝗮𝗹𝘁𝗵: Women with lupus aged 35–44 face a 50× higher risk of heart attack. Cardio-immunology is emerging as a promising area for precision prevention and risk-stratified care. 🧠 $𝟰.𝟱𝗕 𝗖𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗛𝗲𝗮𝗹𝘁𝗵: Autoimmune-linked neuroinflammation may heighten dementia and Alzheimer’s risk — a growing focus of interest for early intervention and biotech innovation. 🩸$𝟱𝟯𝗕 𝗠𝗲𝗻𝘀𝘁𝗿𝘂𝗮𝘁𝗶𝗼𝗻 & 𝗛𝗼𝗿𝗺𝗼𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵: Estrogen directly modulates immune response. As levels fluctuate, inflammation spikes — signaling untapped potential for hormone-immune digital biomarkers and preventive therapies. 👩 $𝟳.𝟱𝗕 𝗠𝗮𝘁𝗲𝗿𝗻𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 & 𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆: Autoimmune risk rises during pregnancy — about 3.2× higher, with 5% of new mothers developing thyroiditis. It’s a natural intersection for collaboration across maternal health, endocrinology, and immunology. 💡 We’re overlooking a vast, fast-growing autoimmune market that cuts across nearly every category of women’s health. Recognizing these intersections could open a powerful new frontier for investors and innovators alike. 🌎 Thank you to Carli Sapir, Colleen Foster, Logan Rocket-Munk, Dominnique Karetsos, Maria Fernanda Peraza Godoy, Lakshmi “Deepa” Yerram MD MHA FAAFP, Natalie Soutonglang, Alexis Y., Sunbal (Somi) Javaid, Amanda Hindlian Laura Clark-Kelly, Eduardo Hariton, MD, MBA, Brian A. Levine, MD, MS, FACOG, Emily Morse, Lyndsey Harper, MD, FACOG, IF, Sharon Malone, Elizabeth Attias, Dr. Yamicia Connor, MD, PhD, MPH, Dr. Giovannina Anthony, Adiv Johnson, Janet Foutty, Malcolm Munro, Ashley Lieser, Dilek Barlow, Nina Levin, Lauren Hardaway, Laura Rogers for this report. 💬 Follow, connect, and join the conversation on my LinkedIn as we work to build a lasting legacy of better outcomes for autoimmune patients. 🔗 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗿𝗲𝗽𝗼𝗿𝘁: https://lnkd.in/gcZvcbvf 🔗 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝗼𝘂𝗿 𝘀𝗽𝗿𝗲𝗮𝗱𝘀𝗵𝗲𝗲𝘁: https://lnkd.in/ggDKtVUU #autoimmune #hormones #menopause #pregnancy #maternalhealth #dementia #Alzheimers #impactinvesting #lupus #rheumatoidarthritis #immunesystem

41

5 Comments

OpenAI makes new healthcare push with new ChatGPT Health. MedTech Innovator LSI American Heart Association Heart Rhythm Society HRX HeartX Accelerator Y Combinator Techstars Health Wildcatters Company Ventures MedTech World Ai ChatGPT Healthcare Microsoft

11

5 Comments

Thrilled to share this milestone partnership with Healthverity! This collaboration brings together the scale of 200+ million patient records with Medeloop's AI-powered analytics platform, empowering pharmaceutical companies, biotech firms, academic medical centers, and government agencies to accelerate research and optimize operations like never before. Excited to see how this will transform the pace of scientific discovery. Check out the full story in Politico below!

58

6 Comments

The digital health space is currently drowning in venture capital. We see companies like Hippocratic AI, Suki, Ambience Healthcare, OpenEvidence, Nabla, Doctronic and Abridge dominating the headlines, announcing massive funding rounds, and promising to revolutionize care. But we need to ask a hard question: Are these platforms built to relentlessly drive down the cost of healthcare and serve the patient, or are they built to justify the next Series C valuation? At the end of the day, a company bound to Private Equity or VC metrics has a fiduciary duty to scale revenue, not necessarily to scale utility. That is why I built AI-HEART Lab (ai-heart.org). I am a solopreneur and operate under a different set of physics. Zero VC money. Zero Private Equity influence. Zero pressure to prioritize commercialization over clinical reality. AI-HEART Lab is physician-built, purely mission-driven infrastructure designed to do one thing: give my fellow clinicians the absolute best, independent tools to help their patients, while aggressively driving down the cost of care. My only metric for success is the number of clinicians I empower and the number of patients we protect. It has reached 7000+ and growing. If you believe that the future of medical AI should be driven by clinical mission rather than venture capital, I need your help. Use the tools at ai-heart.org, share them with your colleagues, and let’s build an ecosystem that actually puts the patient first. American Heart Association, American College of Cardiology, American Board of Internal Medicine - why are we endorsing these platforms? I sure hope that your endorsement is mission and not financially driven. Ami Bhatt, MD and Rohan Khera - I would love to get your thoughts on this. Eric Topol, MD - Is the current funding structure of medical AI incompatible with the ethical mandate to do no harm? Clem Delangue 🤗 - Hugging Face proved that open, collaborative science moves faster and safer than closed-door corporate monopolies. The healthcare sector is currently losing this battle to VC/PE-backed black boxes. I built ai-heart.org to bring the Hugging Face ethos to frontline clinical care. We need the open-source community to help us build transparent, auditable medical AI. How do we accelerate this? Vinod Khosla - If AI is going to transform medicine, shouldn't the infrastructure be owned by the medical community rather than private equity? FDA, Centers for Medicare & Medicaid Services - why are we entertaining companies that drive up the cost of healthcare? #HealthTech #MedicalAI #DigitalHealth #PatientCare #AIinMedicine #ClinicalDecisionSupport

54

8 Comments

We are also thrilled to announce today our Foundation's donation to the Harvard Chan School of Public Health in collaboration with Harvard Medical School to support the design and development of Applied AI solutions for use 'in-the-field' by care workers (with no behavioral health experience) to identify high risk mental health cases and prioritize these for professional support and treatment. This is particularly important in low-income and immigrint communities where there this a dire shortage of mental health services and certified clinicians. Further details will be posted shortly on https://lnkd.in/eSczq_cw

11

How many DTC companies have come into Digital Health and left quickly? "A lot of people do not have the stomach for it." Listen as Dr. Tim Church, MD, MPH, PhD chief medical officer at Wondr Health chats al things Digital Health on this weeks episode of Digital Health Heavyweights Podcast. Watch now: https://lnkd.in/d4e5Cw_j

30

2 Comments

Jessica Rosenworcel, MIT Media Lab director and ex-FCC chair, spotlights tech's charge on women's health via telehealth and AI. A $1T market beckons investors amid policy evolution. Jessica Rosenworcel, the trailblazing executive director of the MIT Media Lab and history's first female FCC chair, just revealed on Bloomberg Businessweek Daily how tech is revolutionizing women's health, from telehealth breakthroughs to fixing a historically overlooked sector ripe for massive investment. This isn't just innovation, it's a strategic pivot: women's health, long sidelined in medical research and funding, now commands a projected $1 trillion global market by 2027, driven by AI, wearables, and policy shifts that savvy investors can't ignore. For business leaders and ambitious professionals, this story hits the bullseye on three fronts. First, it spotlights untapped revenue: companies like Empatica and Affectiva, co-founded by MIT's Rosalind Picard, are pioneering affective computing to track... Continue reading 🔗: https://lnkd.in/eMWfyUjR #WomensHealth #HealthTech #MITMediaLab #Telehealth #WomenInTech

3

1 Comment

I was so glad to participate in this insightful study with Kyra Gardner and Andy Wang as part of their program at Columbia led by Halle Tecco, MPH, MBA. I do believe AI will massively accelerate healthcare innovation, but right now it is stuck in a hype cycle and much of the early AI applications in healthcare just seem to be making the status quo more efficient rather than really transforming the system. We will get there....but there will be bumps and bruises along the way.

14

1 Comment